Samsung Biologics, which has enjoyed a booming contract drug manufacturing streak over the past year, has inked another ...

SAN ANTONIO, April 30, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (OTC: SCPX) ("Scorpius” or "the Company”), an ...

As pharma giants line up one after another to tout their investment plans in the U.S., Regeneron is adopting a different tack ...

/news/home/20250424617540/en/PCI-Pharma-Services-to-Acquire-US-based-Aseptic-Fill-Finish-CDMO-Ajinomoto-Althea ...

Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the ...

Agreement secures additional U.S. manufacturing capacity to help ensure patient access to medicineHOLLY SPRINGS, N.C., April 23, 2025 -- ...

Shares of CDMO opened at $12.50 on Monday. The stock’s fifty day simple moving average is $12.50 and its 200-day simple moving average is $12.05. The company has a quick ratio of 0.92 ...

Revenue increased to Rs 1,720 crore for the fourth quarter as compared with Rs 1,440 crore in the year-ago period, the ...

Laurus Labs stock was quoting at ₹618.50, down 4.18 per cent from the previous session's closing price of ₹645.50 ...

Laurus Labs reports surge in profits and revenue, driven by CDMO and FDF sales, with optimistic outlook for growth.

(“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming CDMO Live 2025 conferen ...